Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Piia Peura"'
Autor:
Marja Airaksinen, Katri Hämeen-Anttila, Marika Pohjanoksa-Mäntylä, Hannes Enlund, Piia Peura, Helena Kastarinen, Jenni Kleme
Publikováno v:
International Journal of Technology Assessment in Health Care. 30:306-311
Objectives: The need to consider the patient perspective in health technology assessments (HTA) has been widely recognized. In July 2012, the Finnish Medicines Agency (Fimea) published a national recommendation for integrating the patient perspective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c522c7e0852f91d8b69e9041461c8e7
https://doi.org/10.1017/s0266462314000282
https://doi.org/10.1017/s0266462314000282
Autor:
Piia Peura, Christian Asseburg, Tuija Oksanen, Juha H. O. Turunen, Janne Martikainen, Timo Purmonen
Publikováno v:
International Journal of Technology Assessment in Health Care. 28:382-389
Background: The cost-effectiveness of triptans in the treatment of migraine has not been assessed since generic sumatriptan entered the Finnish market in 2008.Methods: Using systematic review and mixed treatment comparison, the effectiveness of tript
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57e995be408c92aaf40e7ad0345a4834
https://doi.org/10.1017/s0266462312000517
https://doi.org/10.1017/s0266462312000517
Publikováno v:
Current Medical Research and Opinion. 24:1823-1832
This study evaluated the long-term cost-effectiveness of atorvastatin 20 mg, rosuvastatin 10 mg and simvastatin 40 mg in primary and secondary prevention of CHD in Finland.The effect of statin therapy on the incidence of CHD and the expected total co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f21a33975fc36c54d736ff0132f75f8a
https://doi.org/10.1185/03007990802144705
https://doi.org/10.1185/03007990802144705
Autor:
A E Ades, Kathryn M Rowan, Sheila Harvey, Manu Shankar-Hari, David A Harrison, Jason Madan, Stephen Palmer, Nicky J Welton, Marta Soares, Piia Peura
Publikováno v:
Critical Care
Introduction\ud \ud Prior to investing in a large, multicentre randomised controlled trial (RCT), the National Institute for Health Research in the UK called for an evaluation of the feasibility and value for money of undertaking a trial on intraveno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24bac7bf2927415f552e7690c4ade570
https://pubmed.ncbi.nlm.nih.gov/25434816
https://pubmed.ncbi.nlm.nih.gov/25434816
Autor:
Emma Aarnio, Juha Hartikainen, Janne Martikainen, Piia Peura, Maarit Jaana Korhonen, Risto Huupponen, Arja Helin-Salmivaara
Publikováno v:
Journal of clinical lipidology. 8(1)
Background Although register-based studies on statin adherence are increasing, for administrative data, little is known about the explanatory power of the predictors that explain adherence. Objective The aim was to explore the ability of variables in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3af2167ce62df1aa88787609b10f1a76
https://pubmed.ncbi.nlm.nih.gov/24528692
https://pubmed.ncbi.nlm.nih.gov/24528692
Publikováno v:
Duodecim; laaketieteellinen aikakauskirja. 127(9)
Meta-analysis allows the quantitative combination of results of multiple studies that address similar research questions. Traditional meta-analysis of studies involving a direct comparison of two treatment alternatives can be applied to estimate the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8b9dc2fbb5f7c05f3513f49389d3e3ac
https://pubmed.ncbi.nlm.nih.gov/21648163
https://pubmed.ncbi.nlm.nih.gov/21648163
Autor:
Risto Huupponen, Vesa Kiviniemi, Jaana E. Martikainen, Maarit Jaana Korhonen, Juha Hartikainen, Arja Helin-Salmivaara, Piia Peura
Publikováno v:
European Journal of Clinical Pharmacology
European Journal of Clinical Pharmacology, Springer Verlag, 2011, 67 (9), pp.971-973. ⟨10.1007/s00228-011-1037-0⟩
European Journal of Clinical Pharmacology, Springer Verlag, 2011, 67 (9), pp.971-973. ⟨10.1007/s00228-011-1037-0⟩
Unit of Clinical Pharmacology, Turku University Ho spital, Turku, Finland Corresponding author: Maarit Jaana Korhonen Department of Pharmacology, Drug Development and Th erapeutics, University of Turku, 20014 Turun yliopisto, Finland Tel. +358 40 357
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32a5306902ce0e97f1dd1cc956707e07
https://hal.archives-ouvertes.fr/hal-00685388/file/PEER_stage2_10.1007%2Fs00228-011-1037-0.pdf
https://hal.archives-ouvertes.fr/hal-00685388/file/PEER_stage2_10.1007%2Fs00228-011-1037-0.pdf
